This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 LA Braam , MH Knapen , P Geusens , F Brouns , K Hamulyak , MJ Gerichhausen & C Vermeer (2003) Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73, 21–26.
3 MJ Shearer (2000) Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3, 433–438.
4 R Wallin , DC Sane & SM Hutson (2002) Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system. Thromb Res 108, 221–226.
5 PV Hauschka , JB Lian & PM Gallop (1975) Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72, 3925–3929.
6 PA Price , JW Poser & N Raman (1976) Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci USA 73, 3374–3375.
7 Y Koshihara & K Hoshi (1997) Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12, 431–438.
11 P Szulc , MC Chapuy , PJ Meunier & PD Delmas (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18, 487–488.
12 P Vergnaud , P Garnero , PJ Meunier , G Breart , K Kamihagi & PD Delmas (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82, 719–724.
14 S Cockayne , J Adamson , S Lanham-New , MJ Shearer , S Gilbody & DJ Torgerson (2006) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166, 1256–1261.
15 H Luukinen , SM Kakonen , K Pettersson , K Koski , P Laippala , T Lovgren , SL Kivela & HK Vaananen (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15, 2473–2478.
18 M van Summeren , L Braam , F Noirt , W Kuis & C Vermeer (2007) Pronounced elevation of undercarboxylated osteocalcin in healthy children. Pediatr Res 61, 366–370.
19 SCCMv Coeverden , JC Netelenbos , CMd Ridder , JC Roos , C Popp-Snijders & HA Delemarre-van de Waal (2002) Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol 57, 107–116.
22 SC Van Coeverden , CM De Ridder , JC Roos , MA Van't Hof , JC Netelenbos & HA Delemarre-Van de Waal (2001) Pubertal maturation characteristics and the rate of bone mass development longitudinally toward menarche. J Bone Miner Res 16, 774–781.
24 MHJ Knapen , AC Nieuwenhuijzen Kruseman , RS Wouters & C Vermeer (1998) Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63, 375–379.
25 DA Nelson & WW Koo (1999) Interpretation of absorptiometric bone mass measurements in the growing skeleton: issues and limitations. Calcif Tissue Int 65, 1–3.
28 W Bounds , J Skinner , BR Carruth & P Ziegler (2005) The relationship of dietary and lifestyle factors to bone mineral indexes in children. J Am Diet Assoc 105, 735–741.
29 R Paredes , G Arriagada , F Cruzat , A Villagra , J Olate , K Zaidi , WA van , JB Lian , GS Stein , JL Stein & M Montecino (2004) Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24, 8847–8861.
30 Y Sato , Y Honda , M Kaji , T Asoh , K Hosokawa , I Kondo & K Satoh (2002) Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 31, 114–118.
31 DA Bailey , HA McKay , RL Mirwald , PR Crocker & RA Faulkner (1999) A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res 14, 1672–1679.
32 K Manias , D McCabe & N Bishop (2006) Fractures and recurrent fractures in children; varying effects of environmental factors as well as bone size and mass. Bone 39, 652–657.
33 PE Fournier , R Rizzoli , DO Slosman , G Theintz & JP Bonjour (1997) Asynchrony between the rates of standing height gain and bone mass accumulation during puberty. Osteoporos Int 7, 525–532.
34 RA Faulkner , KS Davison , DA Bailey , RL Mirwald & AD Baxter-Jones (2006) Size-corrected BMD decreases during peak linear growth: implications for fracture incidence during adolescence. J Bone Miner Res 21, 1864–1870.
35 MHJ Knapen , LJ Schurgers & C Vermeer (2007) Vitamin K(2) supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18, 963–972.
36 P Szulc , M Arlot , MC Chapuy , F Duboeuf , PJ Meunier & PD Delmas (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9, 1591–1595.
37 CJ Hernandez , GS Beaupre & DR Carter (2003) A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 14, 843–847.
38 SL Hui , CW Slemenda & CC Johnston (1990) The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1, 30–34.